Yeah Psychemedics $PMD makes the most sense to me for a buyout. They're probably under a ton of pressure since their sales are declining and their shareholders are probably pissed and want their management to change things up. The complete opposite over here :)
Insane Psychemedics had to cancel their streak of 94 consecutive dividend payments so their shareholders aren't too happy with that either.
But it makes sense strategically to combine the "alternative" testing approaches to saliva/blood/urine under one company for better sales coverage. I think financial engineering-wise it also makes sense since $PCHM is undervalued largely because it's an unknown OTC so if you put Psychemedics's earnings multiple on $PCHM, $PCHM looks drastically undervalued in comparison.
News 
Market Data 
Discover 
